Seegene
G42 Healthcare, Seegene to Offer Mobile Molecular Diagnostic Labs in Middle East, North Africa
Under the partnership, the firms will offer the Seegene Mobile Station, a laboratory-on-wheels facility for molecular diagnostic testing.
Seegene Canada, Microbix Ink Distribution Agreement for COVID-Variant Quality Assessment Products
The firm said that Microbix COVID-variant quality assessment products will monitor the workflow accuracy and laboratory testing performance of Seegene variant assays.
Rebus Biosystems Closes $20M Series B Financing Round
Illumina Ventures led the round for the Santa Clara, California-based firm, which is developing applications for its optical detection technology.
As Flu Season Nears, Dx Companies Shift Attention to Multiplex Tests for SARS-CoV-2, Influenza
Premium
Healthcare providers need multiplexed tests that can differentiate the flu from the coronavirus so they can treat patients quickly and appropriately.
Sep 26, 2017
Seegene Inks MOU With Hamilton to Develop MDx System
Jul 6, 2016
Jul 8, 2015
Qiagen, Seegene Ink MDx Development Agreement
May 26, 2015
Seegene Gets CE Mark for GI Infectious Disease Test
Apr 7, 2015
Seegene Launches US Subsidiary
Feb 17, 2015
Seegene Gets FDA Clearance for Herpes MDx Test
Nov 14, 2014